^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR

i
Other names: 4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR
Associations
News
Company:
SZGIMI
Drug class:
CD20-targeted CAR-T immunotherapy, CD123-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy, CD10-targeted CAR-T immunotherapy, CD38-targeted CAR-T immunotherapy, TSLPR-targeted CAR-T immunotherapy
Related drugs:
Associations
News